Home STAY CURRENT IBM uses AI to predict progression of Huntington’s disease

IBM uses AI to predict progression of Huntington’s disease

by CIO AXIS

IBM Research and CHDI Foundation, a non-profit biomedical research organization, are using an artificial intelligence (AI) model that can predict when a person will experience symptoms of Huntington’s disease (HD), a genetic disorder that causes progressive degeneration of nerve cells in the brain, as well as how rapidly these symptoms will progress.

Huntington’s disease is caused by a single gene mutation. According to the Huntington’s Disease Society of America, more than 200,000 Americans are currently at risk of inheriting the genetic-based disease. Most people with Huntington’s disease develop signs and symptoms between the ages of 30 to 50.

In a new study published in the Scientific Reports journal by Nature Research, IBM and CHDI researchers studied the relationship between the pace of subtle cognitive decline in patients before full-fledged symptoms and their brain activity, as shown by a functional MRI.

The results demonstrate that measuring the potential progression of HD could eventually be done from a single brain scan, acquired in one visit.

Recommended for You

Recommended for You

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Close Read More

See Ads